BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.

Many cases of dementia, stroke and late-life depression could be prevented or delayed by managing these 17 risk factors.

The pilot programme — involving 111 of the island’s 3,400 dementia patients — revealed that many were not getting formally diagnosed, and that a lack of funding was burdening support ...

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

An 18-year study of 24,000 older adults found that unmarried people were less at risk for dementia, challenging the belief that married people are healthier.

When a critically injured patient is admitted to the hospital, how much supplemental oxygen should they receive? Research ...

Machine learning algorithms utilizing electronic health records can effectively predict two-year dementia risk among American ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to a new study.

Most patients with Alzheimer's disease and Alzheimer's Disease Related Dementias (ADRD) experience the gradual onset and ...

Early-onset dementia is not as rare as some might think, with approximately 7.5% of dementia patients in the UK believed to be diagnosed before turning 65. This equates to roughly 70,800 people ...

"We are making substantial progress in the fight against dementia," write Drs. Murali Doraiswamy and Eric Stallard.

Researchers have demonstrated how specific biomarkers in the blood can predict the development of dementia up to ten years before diagnosis, among older adults living independently in the community.